9-(3-iodobenzylamino)-1,2,3,4-tetrahydroacridine

**9-(3-Iodobenzylamino)-1,2,3,4-tetrahydroacridine** is a synthetic acridine derivative classified as a small molecule. It is structurally related to tacrine and belongs to the class of organic compounds known as acridines. This compound has been studied primarily in experimental settings and is not approved for clinical use. Its main mechanism of action is as a cholinesterase inhibitor—specifically inhibiting acetylcholinesterase—which suggests potential utility in neurodegenerative diseases such as Alzheimer's disease by increasing acetylcholine levels in the brain. However its development status remains experimental with no reported clinical trials or approvals[1][2][3].

Other names

N-(3-Iodobenzyl)-1,2,3,4-tetrahydroacridinamine9-Acridinamine, 1,2,3,4-tetrahydro-N-(3'-iodobenzyl)-